nodes	percent_of_prediction	percent_of_DWPC	metapath
Zuclopenthixol—Convulsion—Etoposide—sarcoma	0.00169	0.00169	CcSEcCtD
Zuclopenthixol—Dyspepsia—Mitoxantrone—sarcoma	0.00168	0.00169	CcSEcCtD
Zuclopenthixol—Hypertension—Etoposide—sarcoma	0.00168	0.00169	CcSEcCtD
Zuclopenthixol—Constipation—Vincristine—sarcoma	0.00168	0.00168	CcSEcCtD
Zuclopenthixol—Pain—Vincristine—sarcoma	0.00168	0.00168	CcSEcCtD
Zuclopenthixol—Liver function test abnormal—Epirubicin—sarcoma	0.00167	0.00168	CcSEcCtD
Zuclopenthixol—Decreased appetite—Mitoxantrone—sarcoma	0.00166	0.00167	CcSEcCtD
Zuclopenthixol—Migraine—Doxorubicin—sarcoma	0.00165	0.00166	CcSEcCtD
Zuclopenthixol—Fatigue—Mitoxantrone—sarcoma	0.00165	0.00165	CcSEcCtD
Zuclopenthixol—Unspecified disorder of skin and subcutaneous tissue—Etoposide—sarcoma	0.00165	0.00165	CcSEcCtD
Zuclopenthixol—Discomfort—Etoposide—sarcoma	0.00164	0.00164	CcSEcCtD
Zuclopenthixol—Breast disorder—Epirubicin—sarcoma	0.00164	0.00164	CcSEcCtD
Zuclopenthixol—Pain—Mitoxantrone—sarcoma	0.00163	0.00164	CcSEcCtD
Zuclopenthixol—Constipation—Mitoxantrone—sarcoma	0.00163	0.00164	CcSEcCtD
Zuclopenthixol—Hypersensitivity—Thiotepa—sarcoma	0.00163	0.00164	CcSEcCtD
Zuclopenthixol—Nasopharyngitis—Epirubicin—sarcoma	0.00162	0.00163	CcSEcCtD
Zuclopenthixol—Hypersensitivity—Dactinomycin—sarcoma	0.00162	0.00162	CcSEcCtD
Zuclopenthixol—Gastrointestinal pain—Vincristine—sarcoma	0.0016	0.00161	CcSEcCtD
Zuclopenthixol—Alanine aminotransferase increased—Epirubicin—sarcoma	0.0016	0.0016	CcSEcCtD
Zuclopenthixol—Anaphylactic shock—Etoposide—sarcoma	0.00159	0.0016	CcSEcCtD
Zuclopenthixol—Asthenia—Thiotepa—sarcoma	0.00159	0.00159	CcSEcCtD
Zuclopenthixol—Ataxia—Doxorubicin—sarcoma	0.00158	0.00158	CcSEcCtD
Zuclopenthixol—Asthenia—Dactinomycin—sarcoma	0.00157	0.00158	CcSEcCtD
Zuclopenthixol—Feeling abnormal—Mitoxantrone—sarcoma	0.00157	0.00158	CcSEcCtD
Zuclopenthixol—Pruritus—Thiotepa—sarcoma	0.00156	0.00157	CcSEcCtD
Zuclopenthixol—Gastrointestinal pain—Mitoxantrone—sarcoma	0.00156	0.00157	CcSEcCtD
Zuclopenthixol—Thrombocytopenia—Etoposide—sarcoma	0.00155	0.00156	CcSEcCtD
Zuclopenthixol—Tachycardia—Etoposide—sarcoma	0.00155	0.00156	CcSEcCtD
Zuclopenthixol—Eosinophilia—Epirubicin—sarcoma	0.00155	0.00156	CcSEcCtD
Zuclopenthixol—Abdominal pain—Vincristine—sarcoma	0.00155	0.00156	CcSEcCtD
Zuclopenthixol—Body temperature increased—Vincristine—sarcoma	0.00155	0.00156	CcSEcCtD
Zuclopenthixol—Liver function test abnormal—Doxorubicin—sarcoma	0.00155	0.00155	CcSEcCtD
Zuclopenthixol—Skin disorder—Etoposide—sarcoma	0.00154	0.00155	CcSEcCtD
Zuclopenthixol—Hyperhidrosis—Etoposide—sarcoma	0.00154	0.00154	CcSEcCtD
Zuclopenthixol—Breast disorder—Doxorubicin—sarcoma	0.00151	0.00152	CcSEcCtD
Zuclopenthixol—Anorexia—Etoposide—sarcoma	0.00151	0.00152	CcSEcCtD
Zuclopenthixol—Diarrhoea—Thiotepa—sarcoma	0.00151	0.00152	CcSEcCtD
Zuclopenthixol—Abdominal pain—Mitoxantrone—sarcoma	0.00151	0.00152	CcSEcCtD
Zuclopenthixol—Body temperature increased—Mitoxantrone—sarcoma	0.00151	0.00152	CcSEcCtD
Zuclopenthixol—Diarrhoea—Dactinomycin—sarcoma	0.0015	0.00151	CcSEcCtD
Zuclopenthixol—Nasopharyngitis—Doxorubicin—sarcoma	0.0015	0.00151	CcSEcCtD
Zuclopenthixol—Pancytopenia—Epirubicin—sarcoma	0.00149	0.00149	CcSEcCtD
Zuclopenthixol—Hypotension—Etoposide—sarcoma	0.00148	0.00149	CcSEcCtD
Zuclopenthixol—Alanine aminotransferase increased—Doxorubicin—sarcoma	0.00148	0.00148	CcSEcCtD
Zuclopenthixol—Dysuria—Epirubicin—sarcoma	0.00146	0.00147	CcSEcCtD
Zuclopenthixol—Neutropenia—Epirubicin—sarcoma	0.00146	0.00147	CcSEcCtD
Zuclopenthixol—Dizziness—Thiotepa—sarcoma	0.00146	0.00147	CcSEcCtD
Zuclopenthixol—Hypersensitivity—Vincristine—sarcoma	0.00144	0.00145	CcSEcCtD
Zuclopenthixol—Eosinophilia—Doxorubicin—sarcoma	0.00143	0.00144	CcSEcCtD
Zuclopenthixol—Photosensitivity reaction—Epirubicin—sarcoma	0.00143	0.00144	CcSEcCtD
Zuclopenthixol—Paraesthesia—Etoposide—sarcoma	0.00143	0.00143	CcSEcCtD
Zuclopenthixol—Weight increased—Epirubicin—sarcoma	0.00142	0.00143	CcSEcCtD
Zuclopenthixol—Weight decreased—Epirubicin—sarcoma	0.00142	0.00142	CcSEcCtD
Zuclopenthixol—Dyspnoea—Etoposide—sarcoma	0.00142	0.00142	CcSEcCtD
Zuclopenthixol—Hyperglycaemia—Epirubicin—sarcoma	0.00141	0.00142	CcSEcCtD
Zuclopenthixol—Somnolence—Etoposide—sarcoma	0.00141	0.00142	CcSEcCtD
Zuclopenthixol—Hypersensitivity—Mitoxantrone—sarcoma	0.00141	0.00141	CcSEcCtD
Zuclopenthixol—Asthenia—Vincristine—sarcoma	0.00141	0.00141	CcSEcCtD
Zuclopenthixol—Vomiting—Thiotepa—sarcoma	0.00141	0.00141	CcSEcCtD
Zuclopenthixol—Drowsiness—Epirubicin—sarcoma	0.0014	0.0014	CcSEcCtD
Zuclopenthixol—Vomiting—Dactinomycin—sarcoma	0.0014	0.0014	CcSEcCtD
Zuclopenthixol—Rash—Thiotepa—sarcoma	0.00139	0.0014	CcSEcCtD
Zuclopenthixol—Dermatitis—Thiotepa—sarcoma	0.00139	0.0014	CcSEcCtD
Zuclopenthixol—Headache—Thiotepa—sarcoma	0.00138	0.00139	CcSEcCtD
Zuclopenthixol—Rash—Dactinomycin—sarcoma	0.00138	0.00139	CcSEcCtD
Zuclopenthixol—Decreased appetite—Etoposide—sarcoma	0.00138	0.00139	CcSEcCtD
Zuclopenthixol—Pancytopenia—Doxorubicin—sarcoma	0.00138	0.00138	CcSEcCtD
Zuclopenthixol—Gastrointestinal disorder—Etoposide—sarcoma	0.00137	0.00138	CcSEcCtD
Zuclopenthixol—Asthenia—Mitoxantrone—sarcoma	0.00137	0.00138	CcSEcCtD
Zuclopenthixol—Fatigue—Etoposide—sarcoma	0.00137	0.00138	CcSEcCtD
Zuclopenthixol—Jaundice—Epirubicin—sarcoma	0.00136	0.00137	CcSEcCtD
Zuclopenthixol—Pain—Etoposide—sarcoma	0.00136	0.00136	CcSEcCtD
Zuclopenthixol—Constipation—Etoposide—sarcoma	0.00136	0.00136	CcSEcCtD
Zuclopenthixol—Dysuria—Doxorubicin—sarcoma	0.00135	0.00136	CcSEcCtD
Zuclopenthixol—Neutropenia—Doxorubicin—sarcoma	0.00135	0.00136	CcSEcCtD
Zuclopenthixol—Diarrhoea—Vincristine—sarcoma	0.00134	0.00135	CcSEcCtD
Zuclopenthixol—Sweating—Epirubicin—sarcoma	0.00134	0.00134	CcSEcCtD
Zuclopenthixol—Photosensitivity reaction—Doxorubicin—sarcoma	0.00132	0.00133	CcSEcCtD
Zuclopenthixol—Hepatobiliary disease—Epirubicin—sarcoma	0.00132	0.00133	CcSEcCtD
Zuclopenthixol—Weight increased—Doxorubicin—sarcoma	0.00132	0.00132	CcSEcCtD
Zuclopenthixol—Nausea—Thiotepa—sarcoma	0.00131	0.00132	CcSEcCtD
Zuclopenthixol—Weight decreased—Doxorubicin—sarcoma	0.00131	0.00132	CcSEcCtD
Zuclopenthixol—Feeling abnormal—Etoposide—sarcoma	0.00131	0.00131	CcSEcCtD
Zuclopenthixol—Hyperglycaemia—Doxorubicin—sarcoma	0.00131	0.00131	CcSEcCtD
Zuclopenthixol—Diarrhoea—Mitoxantrone—sarcoma	0.00131	0.00131	CcSEcCtD
Zuclopenthixol—Nausea—Dactinomycin—sarcoma	0.0013	0.00131	CcSEcCtD
Zuclopenthixol—Agranulocytosis—Epirubicin—sarcoma	0.0013	0.00131	CcSEcCtD
Zuclopenthixol—Gastrointestinal pain—Etoposide—sarcoma	0.0013	0.0013	CcSEcCtD
Zuclopenthixol—Dizziness—Vincristine—sarcoma	0.0013	0.0013	CcSEcCtD
Zuclopenthixol—Drowsiness—Doxorubicin—sarcoma	0.00129	0.0013	CcSEcCtD
Zuclopenthixol—Jaundice—Doxorubicin—sarcoma	0.00126	0.00126	CcSEcCtD
Zuclopenthixol—Abdominal pain—Etoposide—sarcoma	0.00126	0.00126	CcSEcCtD
Zuclopenthixol—Body temperature increased—Etoposide—sarcoma	0.00126	0.00126	CcSEcCtD
Zuclopenthixol—Vomiting—Vincristine—sarcoma	0.00125	0.00125	CcSEcCtD
Zuclopenthixol—Sweating—Doxorubicin—sarcoma	0.00124	0.00124	CcSEcCtD
Zuclopenthixol—Urinary tract disorder—Epirubicin—sarcoma	0.00124	0.00124	CcSEcCtD
Zuclopenthixol—Rash—Vincristine—sarcoma	0.00124	0.00124	CcSEcCtD
Zuclopenthixol—Dermatitis—Vincristine—sarcoma	0.00123	0.00124	CcSEcCtD
Zuclopenthixol—Oedema peripheral—Epirubicin—sarcoma	0.00123	0.00124	CcSEcCtD
Zuclopenthixol—Connective tissue disorder—Epirubicin—sarcoma	0.00123	0.00124	CcSEcCtD
Zuclopenthixol—Urethral disorder—Epirubicin—sarcoma	0.00123	0.00123	CcSEcCtD
Zuclopenthixol—Headache—Vincristine—sarcoma	0.00123	0.00123	CcSEcCtD
Zuclopenthixol—Hepatobiliary disease—Doxorubicin—sarcoma	0.00122	0.00123	CcSEcCtD
Zuclopenthixol—Vomiting—Mitoxantrone—sarcoma	0.00121	0.00122	CcSEcCtD
Zuclopenthixol—Visual impairment—Epirubicin—sarcoma	0.00121	0.00121	CcSEcCtD
Zuclopenthixol—Agranulocytosis—Doxorubicin—sarcoma	0.00121	0.00121	CcSEcCtD
Zuclopenthixol—Rash—Mitoxantrone—sarcoma	0.0012	0.00121	CcSEcCtD
Zuclopenthixol—Dermatitis—Mitoxantrone—sarcoma	0.0012	0.00121	CcSEcCtD
Zuclopenthixol—Headache—Mitoxantrone—sarcoma	0.0012	0.0012	CcSEcCtD
Zuclopenthixol—Eye disorder—Epirubicin—sarcoma	0.00117	0.00118	CcSEcCtD
Zuclopenthixol—Hypersensitivity—Etoposide—sarcoma	0.00117	0.00118	CcSEcCtD
Zuclopenthixol—Tinnitus—Epirubicin—sarcoma	0.00117	0.00117	CcSEcCtD
Zuclopenthixol—Nausea—Vincristine—sarcoma	0.00116	0.00117	CcSEcCtD
Zuclopenthixol—Cardiac disorder—Epirubicin—sarcoma	0.00116	0.00117	CcSEcCtD
Zuclopenthixol—Urinary tract disorder—Doxorubicin—sarcoma	0.00114	0.00115	CcSEcCtD
Zuclopenthixol—Oedema peripheral—Doxorubicin—sarcoma	0.00114	0.00115	CcSEcCtD
Zuclopenthixol—Asthenia—Etoposide—sarcoma	0.00114	0.00114	CcSEcCtD
Zuclopenthixol—Connective tissue disorder—Doxorubicin—sarcoma	0.00114	0.00114	CcSEcCtD
Zuclopenthixol—Angiopathy—Epirubicin—sarcoma	0.00114	0.00114	CcSEcCtD
Zuclopenthixol—Urethral disorder—Doxorubicin—sarcoma	0.00114	0.00114	CcSEcCtD
Zuclopenthixol—Nausea—Mitoxantrone—sarcoma	0.00113	0.00114	CcSEcCtD
Zuclopenthixol—Immune system disorder—Epirubicin—sarcoma	0.00113	0.00114	CcSEcCtD
Zuclopenthixol—Pruritus—Etoposide—sarcoma	0.00112	0.00113	CcSEcCtD
Zuclopenthixol—Arrhythmia—Epirubicin—sarcoma	0.00112	0.00112	CcSEcCtD
Zuclopenthixol—Visual impairment—Doxorubicin—sarcoma	0.00112	0.00112	CcSEcCtD
Zuclopenthixol—Mental disorder—Epirubicin—sarcoma	0.0011	0.0011	CcSEcCtD
Zuclopenthixol—Erythema—Epirubicin—sarcoma	0.00109	0.0011	CcSEcCtD
Zuclopenthixol—Malnutrition—Epirubicin—sarcoma	0.00109	0.0011	CcSEcCtD
Zuclopenthixol—Diarrhoea—Etoposide—sarcoma	0.00109	0.00109	CcSEcCtD
Zuclopenthixol—Eye disorder—Doxorubicin—sarcoma	0.00108	0.00109	CcSEcCtD
Zuclopenthixol—Tinnitus—Doxorubicin—sarcoma	0.00108	0.00109	CcSEcCtD
Zuclopenthixol—Cardiac disorder—Doxorubicin—sarcoma	0.00108	0.00108	CcSEcCtD
Zuclopenthixol—Flatulence—Epirubicin—sarcoma	0.00107	0.00108	CcSEcCtD
Zuclopenthixol—Tension—Epirubicin—sarcoma	0.00107	0.00108	CcSEcCtD
Zuclopenthixol—Nervousness—Epirubicin—sarcoma	0.00106	0.00106	CcSEcCtD
Zuclopenthixol—Angiopathy—Doxorubicin—sarcoma	0.00105	0.00106	CcSEcCtD
Zuclopenthixol—Dizziness—Etoposide—sarcoma	0.00105	0.00105	CcSEcCtD
Zuclopenthixol—Immune system disorder—Doxorubicin—sarcoma	0.00105	0.00105	CcSEcCtD
Zuclopenthixol—Arrhythmia—Doxorubicin—sarcoma	0.00104	0.00104	CcSEcCtD
Zuclopenthixol—Vision blurred—Epirubicin—sarcoma	0.00103	0.00103	CcSEcCtD
Zuclopenthixol—Mental disorder—Doxorubicin—sarcoma	0.00102	0.00102	CcSEcCtD
Zuclopenthixol—Ill-defined disorder—Epirubicin—sarcoma	0.00101	0.00102	CcSEcCtD
Zuclopenthixol—Vomiting—Etoposide—sarcoma	0.00101	0.00101	CcSEcCtD
Zuclopenthixol—Erythema—Doxorubicin—sarcoma	0.00101	0.00101	CcSEcCtD
Zuclopenthixol—Malnutrition—Doxorubicin—sarcoma	0.00101	0.00101	CcSEcCtD
Zuclopenthixol—Agitation—Epirubicin—sarcoma	0.001	0.00101	CcSEcCtD
Zuclopenthixol—Rash—Etoposide—sarcoma	0.001	0.00101	CcSEcCtD
Zuclopenthixol—Dermatitis—Etoposide—sarcoma	0.001	0.001	CcSEcCtD
Zuclopenthixol—Headache—Etoposide—sarcoma	0.000995	0.000999	CcSEcCtD
Zuclopenthixol—Flatulence—Doxorubicin—sarcoma	0.000994	0.000999	CcSEcCtD
Zuclopenthixol—Tension—Doxorubicin—sarcoma	0.00099	0.000995	CcSEcCtD
Zuclopenthixol—Malaise—Epirubicin—sarcoma	0.000984	0.000988	CcSEcCtD
Zuclopenthixol—Nervousness—Doxorubicin—sarcoma	0.00098	0.000985	CcSEcCtD
Zuclopenthixol—Vertigo—Epirubicin—sarcoma	0.00098	0.000984	CcSEcCtD
Zuclopenthixol—Syncope—Epirubicin—sarcoma	0.000978	0.000982	CcSEcCtD
Zuclopenthixol—Leukopenia—Epirubicin—sarcoma	0.000976	0.000981	CcSEcCtD
Zuclopenthixol—Palpitations—Epirubicin—sarcoma	0.000964	0.000968	CcSEcCtD
Zuclopenthixol—Loss of consciousness—Epirubicin—sarcoma	0.000959	0.000963	CcSEcCtD
Zuclopenthixol—Vision blurred—Doxorubicin—sarcoma	0.000951	0.000955	CcSEcCtD
Zuclopenthixol—Convulsion—Epirubicin—sarcoma	0.000945	0.000949	CcSEcCtD
Zuclopenthixol—Nausea—Etoposide—sarcoma	0.000943	0.000947	CcSEcCtD
Zuclopenthixol—Hypertension—Epirubicin—sarcoma	0.000942	0.000946	CcSEcCtD
Zuclopenthixol—Ill-defined disorder—Doxorubicin—sarcoma	0.000936	0.000941	CcSEcCtD
Zuclopenthixol—Myalgia—Epirubicin—sarcoma	0.000929	0.000933	CcSEcCtD
Zuclopenthixol—Agitation—Doxorubicin—sarcoma	0.000927	0.000932	CcSEcCtD
Zuclopenthixol—Anxiety—Epirubicin—sarcoma	0.000925	0.000929	CcSEcCtD
Zuclopenthixol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.000922	0.000926	CcSEcCtD
Zuclopenthixol—Discomfort—Epirubicin—sarcoma	0.000917	0.000922	CcSEcCtD
Zuclopenthixol—Malaise—Doxorubicin—sarcoma	0.00091	0.000914	CcSEcCtD
Zuclopenthixol—Dry mouth—Epirubicin—sarcoma	0.000908	0.000912	CcSEcCtD
Zuclopenthixol—Vertigo—Doxorubicin—sarcoma	0.000907	0.000911	CcSEcCtD
Zuclopenthixol—Syncope—Doxorubicin—sarcoma	0.000905	0.000909	CcSEcCtD
Zuclopenthixol—Leukopenia—Doxorubicin—sarcoma	0.000903	0.000907	CcSEcCtD
Zuclopenthixol—Palpitations—Doxorubicin—sarcoma	0.000892	0.000896	CcSEcCtD
Zuclopenthixol—Anaphylactic shock—Epirubicin—sarcoma	0.00089	0.000894	CcSEcCtD
Zuclopenthixol—Loss of consciousness—Doxorubicin—sarcoma	0.000887	0.000891	CcSEcCtD
Zuclopenthixol—Shock—Epirubicin—sarcoma	0.000876	0.00088	CcSEcCtD
Zuclopenthixol—Convulsion—Doxorubicin—sarcoma	0.000874	0.000878	CcSEcCtD
Zuclopenthixol—Nervous system disorder—Epirubicin—sarcoma	0.000873	0.000877	CcSEcCtD
Zuclopenthixol—Thrombocytopenia—Epirubicin—sarcoma	0.000872	0.000875	CcSEcCtD
Zuclopenthixol—Hypertension—Doxorubicin—sarcoma	0.000871	0.000875	CcSEcCtD
Zuclopenthixol—Tachycardia—Epirubicin—sarcoma	0.000869	0.000873	CcSEcCtD
Zuclopenthixol—Skin disorder—Epirubicin—sarcoma	0.000865	0.000868	CcSEcCtD
Zuclopenthixol—Hyperhidrosis—Epirubicin—sarcoma	0.000861	0.000864	CcSEcCtD
Zuclopenthixol—Myalgia—Doxorubicin—sarcoma	0.000859	0.000863	CcSEcCtD
Zuclopenthixol—Anxiety—Doxorubicin—sarcoma	0.000856	0.00086	CcSEcCtD
Zuclopenthixol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.000853	0.000857	CcSEcCtD
Zuclopenthixol—Discomfort—Doxorubicin—sarcoma	0.000849	0.000853	CcSEcCtD
Zuclopenthixol—Anorexia—Epirubicin—sarcoma	0.000848	0.000852	CcSEcCtD
Zuclopenthixol—Dry mouth—Doxorubicin—sarcoma	0.00084	0.000844	CcSEcCtD
Zuclopenthixol—Hypotension—Epirubicin—sarcoma	0.000832	0.000836	CcSEcCtD
Zuclopenthixol—Anaphylactic shock—Doxorubicin—sarcoma	0.000824	0.000827	CcSEcCtD
Zuclopenthixol—Musculoskeletal discomfort—Epirubicin—sarcoma	0.000811	0.000815	CcSEcCtD
Zuclopenthixol—Shock—Doxorubicin—sarcoma	0.00081	0.000814	CcSEcCtD
Zuclopenthixol—Nervous system disorder—Doxorubicin—sarcoma	0.000808	0.000811	CcSEcCtD
Zuclopenthixol—Thrombocytopenia—Doxorubicin—sarcoma	0.000806	0.00081	CcSEcCtD
Zuclopenthixol—Insomnia—Epirubicin—sarcoma	0.000805	0.000809	CcSEcCtD
Zuclopenthixol—Tachycardia—Doxorubicin—sarcoma	0.000804	0.000807	CcSEcCtD
Zuclopenthixol—Skin disorder—Doxorubicin—sarcoma	0.0008	0.000804	CcSEcCtD
Zuclopenthixol—Paraesthesia—Epirubicin—sarcoma	0.000799	0.000803	CcSEcCtD
Zuclopenthixol—Hyperhidrosis—Doxorubicin—sarcoma	0.000796	0.0008	CcSEcCtD
Zuclopenthixol—Dyspnoea—Epirubicin—sarcoma	0.000794	0.000797	CcSEcCtD
Zuclopenthixol—Somnolence—Epirubicin—sarcoma	0.000791	0.000795	CcSEcCtD
Zuclopenthixol—Anorexia—Doxorubicin—sarcoma	0.000785	0.000789	CcSEcCtD
Zuclopenthixol—Dyspepsia—Epirubicin—sarcoma	0.000784	0.000787	CcSEcCtD
Zuclopenthixol—Decreased appetite—Epirubicin—sarcoma	0.000774	0.000777	CcSEcCtD
Zuclopenthixol—Hypotension—Doxorubicin—sarcoma	0.00077	0.000773	CcSEcCtD
Zuclopenthixol—Gastrointestinal disorder—Epirubicin—sarcoma	0.000768	0.000772	CcSEcCtD
Zuclopenthixol—Fatigue—Epirubicin—sarcoma	0.000767	0.000771	CcSEcCtD
Zuclopenthixol—Constipation—Epirubicin—sarcoma	0.000761	0.000765	CcSEcCtD
Zuclopenthixol—Pain—Epirubicin—sarcoma	0.000761	0.000765	CcSEcCtD
Zuclopenthixol—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.00075	0.000754	CcSEcCtD
Zuclopenthixol—Insomnia—Doxorubicin—sarcoma	0.000745	0.000748	CcSEcCtD
Zuclopenthixol—Paraesthesia—Doxorubicin—sarcoma	0.00074	0.000743	CcSEcCtD
Zuclopenthixol—Dyspnoea—Doxorubicin—sarcoma	0.000734	0.000738	CcSEcCtD
Zuclopenthixol—Feeling abnormal—Epirubicin—sarcoma	0.000734	0.000737	CcSEcCtD
Zuclopenthixol—Somnolence—Doxorubicin—sarcoma	0.000732	0.000735	CcSEcCtD
Zuclopenthixol—Gastrointestinal pain—Epirubicin—sarcoma	0.000728	0.000731	CcSEcCtD
Zuclopenthixol—Dyspepsia—Doxorubicin—sarcoma	0.000725	0.000728	CcSEcCtD
Zuclopenthixol—Decreased appetite—Doxorubicin—sarcoma	0.000716	0.000719	CcSEcCtD
Zuclopenthixol—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000711	0.000714	CcSEcCtD
Zuclopenthixol—Fatigue—Doxorubicin—sarcoma	0.00071	0.000713	CcSEcCtD
Zuclopenthixol—Constipation—Doxorubicin—sarcoma	0.000704	0.000707	CcSEcCtD
Zuclopenthixol—Pain—Doxorubicin—sarcoma	0.000704	0.000707	CcSEcCtD
Zuclopenthixol—Abdominal pain—Epirubicin—sarcoma	0.000704	0.000707	CcSEcCtD
Zuclopenthixol—Body temperature increased—Epirubicin—sarcoma	0.000704	0.000707	CcSEcCtD
Zuclopenthixol—Feeling abnormal—Doxorubicin—sarcoma	0.000679	0.000682	CcSEcCtD
Zuclopenthixol—Gastrointestinal pain—Doxorubicin—sarcoma	0.000674	0.000677	CcSEcCtD
Zuclopenthixol—Hypersensitivity—Epirubicin—sarcoma	0.000656	0.000659	CcSEcCtD
Zuclopenthixol—Abdominal pain—Doxorubicin—sarcoma	0.000651	0.000654	CcSEcCtD
Zuclopenthixol—Body temperature increased—Doxorubicin—sarcoma	0.000651	0.000654	CcSEcCtD
Zuclopenthixol—Asthenia—Epirubicin—sarcoma	0.000639	0.000642	CcSEcCtD
Zuclopenthixol—Pruritus—Epirubicin—sarcoma	0.00063	0.000633	CcSEcCtD
Zuclopenthixol—Diarrhoea—Epirubicin—sarcoma	0.000609	0.000612	CcSEcCtD
Zuclopenthixol—Hypersensitivity—Doxorubicin—sarcoma	0.000607	0.00061	CcSEcCtD
Zuclopenthixol—HTR2A—pulmonary artery—sarcoma	0.000595	0.133	CbGeAlD
Zuclopenthixol—Asthenia—Doxorubicin—sarcoma	0.000591	0.000594	CcSEcCtD
Zuclopenthixol—Dizziness—Epirubicin—sarcoma	0.000589	0.000591	CcSEcCtD
Zuclopenthixol—Pruritus—Doxorubicin—sarcoma	0.000583	0.000585	CcSEcCtD
Zuclopenthixol—Vomiting—Epirubicin—sarcoma	0.000566	0.000569	CcSEcCtD
Zuclopenthixol—Diarrhoea—Doxorubicin—sarcoma	0.000564	0.000566	CcSEcCtD
Zuclopenthixol—Rash—Epirubicin—sarcoma	0.000561	0.000564	CcSEcCtD
Zuclopenthixol—Dermatitis—Epirubicin—sarcoma	0.000561	0.000563	CcSEcCtD
Zuclopenthixol—Headache—Epirubicin—sarcoma	0.000558	0.00056	CcSEcCtD
Zuclopenthixol—Dizziness—Doxorubicin—sarcoma	0.000545	0.000547	CcSEcCtD
Zuclopenthixol—Nausea—Epirubicin—sarcoma	0.000529	0.000531	CcSEcCtD
Zuclopenthixol—Vomiting—Doxorubicin—sarcoma	0.000524	0.000526	CcSEcCtD
Zuclopenthixol—Rash—Doxorubicin—sarcoma	0.000519	0.000522	CcSEcCtD
Zuclopenthixol—Dermatitis—Doxorubicin—sarcoma	0.000519	0.000521	CcSEcCtD
Zuclopenthixol—Headache—Doxorubicin—sarcoma	0.000516	0.000518	CcSEcCtD
Zuclopenthixol—Nausea—Doxorubicin—sarcoma	0.000489	0.000491	CcSEcCtD
Zuclopenthixol—HTR2A—hindlimb—sarcoma	0.00036	0.0807	CbGeAlD
Zuclopenthixol—HTR2A—appendage—sarcoma	0.000309	0.0692	CbGeAlD
Zuclopenthixol—DRD5—hematopoietic system—sarcoma	0.000308	0.0689	CbGeAlD
Zuclopenthixol—DRD5—lymphoid tissue—sarcoma	0.000216	0.0485	CbGeAlD
Zuclopenthixol—HTR2A—endothelium—sarcoma	0.000186	0.0418	CbGeAlD
Zuclopenthixol—ADRA1A—hematopoietic system—sarcoma	0.000142	0.0317	CbGeAlD
Zuclopenthixol—HRH1—myometrium—sarcoma	0.000128	0.0286	CbGeAlD
Zuclopenthixol—ADRA2A—myometrium—sarcoma	0.000125	0.0281	CbGeAlD
Zuclopenthixol—ADRA2A—seminal vesicle—sarcoma	0.000113	0.0254	CbGeAlD
Zuclopenthixol—HRH1—hematopoietic system—sarcoma	0.00011	0.0246	CbGeAlD
Zuclopenthixol—ADRA2A—hematopoietic system—sarcoma	0.000108	0.0241	CbGeAlD
Zuclopenthixol—HRH1—connective tissue—sarcoma	0.000106	0.0237	CbGeAlD
Zuclopenthixol—ADRA2A—connective tissue—sarcoma	0.000104	0.0232	CbGeAlD
Zuclopenthixol—HTR2A—embryo—sarcoma	0.000103	0.023	CbGeAlD
Zuclopenthixol—ADRA1A—lymphoid tissue—sarcoma	9.97e-05	0.0224	CbGeAlD
Zuclopenthixol—HRH1—smooth muscle tissue—sarcoma	9.66e-05	0.0216	CbGeAlD
Zuclopenthixol—HTR2A—hematopoietic system—sarcoma	9.16e-05	0.0205	CbGeAlD
Zuclopenthixol—HTR2A—connective tissue—sarcoma	8.82e-05	0.0198	CbGeAlD
Zuclopenthixol—CYP2D6—hematopoietic system—sarcoma	8.34e-05	0.0187	CbGeAlD
Zuclopenthixol—ADRA2A—cardiac atrium—sarcoma	8.18e-05	0.0183	CbGeAlD
Zuclopenthixol—ADRA2A—uterus—sarcoma	8.13e-05	0.0182	CbGeAlD
Zuclopenthixol—HTR2A—smooth muscle tissue—sarcoma	8.06e-05	0.0181	CbGeAlD
Zuclopenthixol—DRD2—testis—sarcoma	7.61e-05	0.0171	CbGeAlD
Zuclopenthixol—ADRA1A—liver—sarcoma	7.34e-05	0.0164	CbGeAlD
Zuclopenthixol—HRH1—tendon—sarcoma	7.26e-05	0.0163	CbGeAlD
Zuclopenthixol—ADRA2A—tendon—sarcoma	7.13e-05	0.016	CbGeAlD
Zuclopenthixol—HTR2A—tendon—sarcoma	6.06e-05	0.0136	CbGeAlD
Zuclopenthixol—HRH1—testis—sarcoma	6.01e-05	0.0135	CbGeAlD
Zuclopenthixol—ADRA2A—testis—sarcoma	5.9e-05	0.0132	CbGeAlD
Zuclopenthixol—HTR2A—testis—sarcoma	5.02e-05	0.0112	CbGeAlD
Zuclopenthixol—HTR2A—liver—sarcoma	4.74e-05	0.0106	CbGeAlD
Zuclopenthixol—CYP2D6—testis—sarcoma	4.57e-05	0.0102	CbGeAlD
Zuclopenthixol—HRH1—lymph node—sarcoma	4.35e-05	0.00976	CbGeAlD
Zuclopenthixol—CYP2D6—liver—sarcoma	4.32e-05	0.00969	CbGeAlD
Zuclopenthixol—ADRA2A—lymph node—sarcoma	4.28e-05	0.00959	CbGeAlD
